Skip to main content
SpringerLink
Log in

Neoplastic Skin Diseases in Organ Transplant Recipients

  • Review Article
  • Published:
American Journal of Cancer

Abstract

The number of organ transplant recipients (OTR) is growing steadily thanks to the improvements in organ preservation, transplantation surgery and immunosuppressive treatments. For the graft to function well it requires patients to be, in most cases, on lifelong immunosuppressive treatment. As a consequence, these patients have a high risk for developing various malignancies, namely those associated with viruses. Skin cancers, especially squamous cell carcinomas (SCC), account for the most frequent malignancies, affecting about 50% of patients within 20 years of transplantation. SCC tend to be multiple, may have a life-threatening course and seem to be a hallmark for developing other malignancies. Risk factors for skin carcinomas include ultraviolet light, immunosuppression, age, fair skin type, genetic factors and human papillomavirus infection. The frequency of skin carcinomas could be decreased by adequately educating patients regarding sun protection after transplantation. The incidence of Kaposi’s sarcoma (KS), associated with a recently discovered virus (KS-associated herpesvirus/Human Herpes Virus 8), lymphomas, melanomas, anogenital carcinoma and some other rare tumors (such as Merkel cell carcinomas and sarcomas) is also increased in patients receiving immunosuppression, and may have an aggressive course.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Webb MC, Compton F, Andrews PA, et al. Skin tumours posttransplantation: a retrospective analysis of 28 years experience at a single centre. Transplant Proc 1997; 29: 828–30

    Article  PubMed  CAS  Google Scholar 

  2. Behrend M, Kolditz M, Kliem V, et al. Malignancies in patients under long-term immunosuppression after kidney transplantation. Transplant Proc 1997; 29: 834–5

    Article  PubMed  CAS  Google Scholar 

  3. Hiesse C, Rieu P, Kriaa F, et al. Malignancy after renal transplantation: analysis of incidence and risk factors in 1700 patients followed during a 25-year period. Transplant Proc 1997; 29: 831–3

    Article  PubMed  CAS  Google Scholar 

  4. Mihalov ML, Gattuso P, Abraham K, et al. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. Clin Transplant 1996; 10: 248–55

    PubMed  CAS  Google Scholar 

  5. Montagnino G, Lorca E, Rantino A, et al. Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment. Clin Transplant 1996; 10: 461–9

    PubMed  CAS  Google Scholar 

  6. Walder BK, Robertson MR, Jeremy D. Skin cancer and immunosuppression. Lancet 1971; II: 1282–3

    Article  Google Scholar 

  7. Hartevelt MM, Bouwes Bavinck JN, Koote AMM, et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49: 506–9

    Article  PubMed  CAS  Google Scholar 

  8. Blohmé I, Larkö O. Skin lesions in renal transplant recipients after 10–23 years of immunosuppressive therapy. Acta Derm Venereol 1990; 70: 491–4

    PubMed  Google Scholar 

  9. Birkeland S, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in Nordic countries. Int J Cancer 1995; 60: 183–9

    Article  PubMed  CAS  Google Scholar 

  10. Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177–86

    Article  PubMed  CAS  Google Scholar 

  11. Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 1993; 7: 431–45

    PubMed  CAS  Google Scholar 

  12. Euvrard S, Kanitakis J, Pouteil-Noble C, et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995; 33: 222–9

    Article  PubMed  CAS  Google Scholar 

  13. Fernandez-Gonzalez A, Espana A, Redondo P. Solid tumors after heart transplantation. Ann Thorac Surg 1996; 62: 943–4

    PubMed  CAS  Google Scholar 

  14. Ternesten-Bratel A, Kjellstrom C, Ricksten A. Specific expression of Epstein-Barr virus in cutaneous squamous cell carcinomas from heart transplant recipients. Transplantation 1998; 66: 1524–9

    Article  PubMed  CAS  Google Scholar 

  15. Lampros TD, Cobanoglu A, Parker F, et al. Squamous and basal cell carcinoma in heart transplant recipients. J Heart Lung Transplant 1998; 17: 586–91

    PubMed  CAS  Google Scholar 

  16. Hoagland P, Moore K, King J, et al. High incidence and clinical course of aggressive skin cancer in heart transplant patients: a single-center study. Transplant Proc 1998; 30: 1124–6

    Article  PubMed  Google Scholar 

  17. Adamson R, Obispo E, Dychter S, et al. High incidence and clinical course of aggressive skin cancer in heart transplant patients: a single-center study. Transplant Proc 1998; 30: 1124–6

    Article  PubMed  CAS  Google Scholar 

  18. Veness MJ, Quinn DI, Ong CS, et al. Aggressive cutaneous malignancies following cardiothoracic transplantation. Cancer 1999; 85: 1759–64

    Article  Google Scholar 

  19. Ong CS, Keogh AM, Kossard S, et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999; 40: 27–34

    Article  PubMed  CAS  Google Scholar 

  20. Naldi L, Fortina AB, Lovati S, et al. Risk of nonmelanoma skin cancer in Italian organ transplant recipients: a registry-based study. Transplantation 2000; 70: 1479–84

    Article  PubMed  CAS  Google Scholar 

  21. Caforio AL, Fortina AB, Piaserico S, et al. Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy. Circulation 2000; 102: 222–7

    Article  Google Scholar 

  22. Pollard JD, Hanasono M, Mikulec A, et al. Head and neck cancer in cardiothoracic transplant recipients. Laryngoscope 2000; 110: 1257–61

    Article  PubMed  CAS  Google Scholar 

  23. Frezza EE, Fung JJ, VanThiel DH. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology 1997; 44: 1172–81

    PubMed  CAS  Google Scholar 

  24. Jonas S, Rayes N, Neumann U, et al. De Novo malignancies after liver transplantation using Tacrolimus-based protocols or Cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 1997; 80: 1141–50

    Article  PubMed  CAS  Google Scholar 

  25. Jain AB, Yee LD, Nalesnik MA, et al. Comparative incidence of de novo non-lymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998; 66: 1193–200

    Article  PubMed  CAS  Google Scholar 

  26. Bouwes-Bavinck JN, Hardie D, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. Transplantation 1996; 61: 715–21

    Article  PubMed  CAS  Google Scholar 

  27. Bordea C, Cortina-Borja M, Wojnarowska F, et al. Distribution of upper limb skin cancers in relation to arteriovenous fistula side in renal transplant recipients. Transplantation 2001; 71: 143–5

    Article  PubMed  CAS  Google Scholar 

  28. Euvrard S, Kanitakis J, Pouteil-Noble C, et al. Aggressive squamous cell carcinomas in organ transplant recipients. Transplant Proc 1995; 27: 1767–8

    PubMed  CAS  Google Scholar 

  29. Penn I. De novo malignancy in pediatrie organ transplant recipients. Pediatr Transplant 1998; 2: 56–63

    PubMed  CAS  Google Scholar 

  30. Euvrard S, Kanitakis J, Cochat P, et al. Skin diseases in children with organ transplants. J Am Acad Dermatol 2001; 44: 932–9

    Article  PubMed  CAS  Google Scholar 

  31. Hoyo E, Kanitakis J, Euvrard S, et al. Proliferation characteristics of cutaneous squamous cell carcinomas developing in organ graft recipients. Arch Dermatol Mar; 129 (3): 324–7

  32. Kanitakis J, Narvaez D, Euvrard S, et al. Proliferation markers Ki67 and PCNA in cutaneous squamous cell carcinomas: lack of prognostic value. Br J Dermatol 1997; 136: 643–4

    Article  PubMed  CAS  Google Scholar 

  33. Narvaez D, Kanitakis J, Euvrard S, et al. Comparative nuclear morphometric analysis of aggressive and non-aggressive squamous cell carcinomas of the skin. Acta Derm Venereol 1997; 77: 115–7

    PubMed  CAS  Google Scholar 

  34. Boyle J, Briggs JD, Mackie RM, et al. Cancer, warts, and sunshine in renal transplant patients. Lancet 1984; I: 702–5

    Article  Google Scholar 

  35. Sheil AGR, Flavel S, Disney APS, et al. Cancer incidence in renal transplant patients treated with azathioprine or cyclosporine. Transplant Proc 1987; 19: 2214–6

    PubMed  CAS  Google Scholar 

  36. Glover MT, Deeks JJ, Raftery MJ, et al. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients [letter]. Lancet 1997; 349: 398

    Google Scholar 

  37. Hoshida Y, Tsukuma H, Yasunaga Y, et al. Cancer risk after renal transplantation in Japan. Int J Cancer 1997; 71: 517–20

    Article  PubMed  CAS  Google Scholar 

  38. Bouwes-Bavinck JN, de Boers A, Vermeer BJ, et al. Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 1993; 129: 242–9

    Article  Google Scholar 

  39. Butt A, Roberts DL. Renal transplant recipients and protection from sun: need for education. Lancet 1997; 349: 179–80

    Article  PubMed  CAS  Google Scholar 

  40. Seukeran DC, Newstead CG, Cunliffe WJ. The compliance of renal transplant recipients with advice about sun protection measures. Br J Dermatol 1998; 138: 301–3

    Article  PubMed  CAS  Google Scholar 

  41. Cowen EW, Billingsley EM. Awareness of skin cancer by kidney transplant patients. J Am Acad Dermatol 1999; 40: 697–701

    Article  PubMed  CAS  Google Scholar 

  42. Kurimoto I, Streilein JW. UV-induced immunosuppression. In: Euvrard S, Kanitakis J, Claudy A, editors. Skin diseases after organ transplantation. Paris: John Libbey Eurotext, 1998: 29–36

  43. Galvao MM, Sotto MN, Kihara SM, et al. Lymphocyte subsets and Langerhans cells in sun-protected and sun-exposed skin of immunosuppressed renal allograft recipients. J Am Acad Dermatol 1998; 38: 38–44

    Article  PubMed  CAS  Google Scholar 

  44. Servitje O, Seron D, Ferrer I, et al. Quantitative and morphometric analysis of Langerhans cells in non-exposed skin in renal transplant patients. J Cutan Pathol 1991; 18: 106–11

    Article  PubMed  CAS  Google Scholar 

  45. Ducloux D, Carron PL, Rebibou JM, et al. CD4 lymphopenia as a risk factor for skin cancers in renal transplant recipients. Transplantation 1998; 65: 1270–2

    Article  PubMed  CAS  Google Scholar 

  46. Arends MJ, Benton EC, McLaren KM, et al. Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy. Br J Cancer 1997; 75: 722–8

    Article  PubMed  CAS  Google Scholar 

  47. Euvrard S, Pouteil-Noble C, Kanitakis J, et al. Successive occurrence of T-cell and B-cell lymphomas after renal transplantation in a patient with multiple cutaneous squamous cell carcinomas. N Engl J Med 1992; 327: 1924–7

    Article  PubMed  CAS  Google Scholar 

  48. Barroso-Vicens E, Ramirez G, Rabb H. Multiple primary malignancies in a renal transplant patient. Transplantation 1996; 61: 1655–6

    Article  PubMed  CAS  Google Scholar 

  49. Kanitakis J, Euvrard S, Montazeri A, et al. Atypical fibroxanthoma in a renal graft recipient. J Am Acad Dermatol 1996; 35: 262–4

    Article  PubMed  CAS  Google Scholar 

  50. Dantal J, Hourmant M, Cantarovich D, et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998; 351: 623–8

    Article  PubMed  CAS  Google Scholar 

  51. Ramos HC, Reyes J, Abu-Elmagd K, et al. Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 1995; 59: 212–7

    PubMed  CAS  Google Scholar 

  52. Barr B, Benton EC, McLaren K, et al. Human papillomavirus infection and skin cancer in renal allograft recipients. Lancet 1989; I: 124–9

    Article  Google Scholar 

  53. Euvrard S, Chardonnet Y, Pouteil-Noble C, et al. Association of skin malignancies with various and multiple carcinogenic and non carcinogenic human papillo-maviruses in renal transplant recipients. Cancer 1993; 72: 2198–206

    Article  PubMed  CAS  Google Scholar 

  54. Chardonnet Y, Viac J, Euvrard S. Warts and squamous cell carcinomas in organ transplant patients: is the human papillomavirus responsible for carcinogenesis? Eur J Dermatol 1997; 7: 5–11

    Google Scholar 

  55. DeVilliers EM, Lavergne D, McLaren K, et al. Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer 1997; 73: 356–61

    Article  PubMed  Google Scholar 

  56. Harwood CA, McGregor JM, Proby CM, et al. Human papillomavirus and the development of non-melanoma skin cancer. J Clin Pathol 1999; 52: 249–53

    Article  PubMed  CAS  Google Scholar 

  57. Harwood CA, Surentheran T, McGregor JM, et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocom-petent individuals. J Med Virol 2000; 61: 289–97

    Article  PubMed  CAS  Google Scholar 

  58. Berkhout R, Bouwes-Bavinck J, ter Schegget J. Persistence of Human Papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000; 38: 2087–96

    PubMed  CAS  Google Scholar 

  59. de Jong-Tieben L, Berkhout R, ter Schegget J, et al. The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: a clinical study to assess risk factors for keratotic skin lesions and skin cancer. Transplantation 2000; 69: 44–9

    Article  PubMed  Google Scholar 

  60. Boxman I, Berkhout R, Mulder L, et al. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997; 108: 712–5

    Article  PubMed  CAS  Google Scholar 

  61. Boxman I, Mulder L, Russel A, et al. Human papillomavirus type 5 is commonly present in immunosuppressed and immunocompetent individuals. Br J Dermatol 1999; 141: 246–9

    Article  PubMed  CAS  Google Scholar 

  62. Shamanin V, Zur Hausen H, Lavergne D, et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and non-immunosuppressed patients. J Natl Cancer Inst 1996; 88: 802–11

    Article  PubMed  CAS  Google Scholar 

  63. McGregor JM, Berkhout RJ, Rozycka M, et al. P53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status. Qncogene 1997; 15: 1737–40

    CAS  Google Scholar 

  64. Cairey-Remonnay S, Humbey O, Mougin C, et al. TP53 polymorphism of exon 4 at codon 72 in cutaneous squamous cell carcinoma and benign epethelial lesions of renal transplant recipients and immunocompetent individuals: lack of correlation with HPV status. J Invest Dermatol 2002; In press

  65. Cathomas G, Tamm M, McGandy CE, et al. Absence of Kaposi’s sarcoma-associated human herpes virus 8 in transplantation-related tumors other than Kaposi’s sarcoma. Transplant Proc 1997; 29: 836–7

    Article  PubMed  CAS  Google Scholar 

  66. Dupin N, Gorin I, Escande JP, et al. Lack of evidence of any association between human herpesvirus 8 and various skin tumors from both immunocompetent and immunosuppressed patients [letter]. Arch Dermatol 1997; 133: 537

    Google Scholar 

  67. Lebbé C, Tatoud R, Morel P, et al. Human Herpesvirus 8 sequences are not detected in epithelial tumors from patients receiving transplants [letter]. Arch Dermatol 1997; 133: 111

    Google Scholar 

  68. Thomas DW, Ramsahoye B, Jasani B, et al. Epstein-Barr Virus in squamous cell carcinoma after renal transplantation. Transplantation 1995; 60: 390–2

    Article  PubMed  CAS  Google Scholar 

  69. Huston BM, Maia DM. Absence of latent Epstein-Barr virus in cutaneous squamoproliferative lesions after solid organ transplantation. Mod Pathol 1997; 10: 1188–93

    PubMed  CAS  Google Scholar 

  70. Kolhler S, Kamel OW, Chang PP, et al. Absence of herpesvirus 8 and Epstein-Barr virus genome sequences in cutaneous epithelial neoplasms arising in immunosuppressed organ-transplant patients. J Cutan Pathol 1997; 24: 559–63

    Article  Google Scholar 

  71. Bouwes-Bavinck JN, Claas F, Hardie D, et al. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia. J Invest Dermatol 1997; 108: 708–11

    Article  PubMed  CAS  Google Scholar 

  72. Marshall SE, Bordea C, Haldar N, et al. Glutathione S-transferase polymorphisms and skin cancer after renal transplantation. Kidney Int 2000; 58: 2186–93

    Article  PubMed  CAS  Google Scholar 

  73. VanZuuren E, Posma A, Scholtens R, et al. Resurfacing the back of the hand as treatment and prevention of multiple skin cancers in kidney transplant recipients. J Am Acad Dermatol 1994; 31: 760–4

    Article  PubMed  Google Scholar 

  74. Euvrard S. General guidelines. In: Euvrard S, Kanitakis J, Claudy, et al., editors. Skin diseases after organ transplantation. Paris: John Libbey Eurotext, 1998: 29–36

    Google Scholar 

  75. Euvrard S, Kanitakis J, Thivolet J, et al. Retinoids for the management of dermatological complications of organ transplantation. Biodrugs 1997; 3: 176–84

    Article  Google Scholar 

  76. Euvrard S, Verschoore M, Touraine JL, et al. Topical retinoids for warts and keratoses in transplant recipients. Lancet 1992; 340: 48–9

    Article  PubMed  CAS  Google Scholar 

  77. Rook AH, Jaworsky C, Nguyen T, et al. Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients. Transplantation 1995; 59: 714–9

    Article  PubMed  CAS  Google Scholar 

  78. Christiansen TN, Freije JE, Neuburg M, et al. Cutaneous squamous cell carcinoma metastatic to the parotid gland in a transplant patient. Clin Transplant 1996; 10: 561–3

    PubMed  CAS  Google Scholar 

  79. Magnone M, Holley J, Shapiro R, et al. Interferon a-induced acute renal allograft rejection. Transplantation 1994; 59: 1068–70

    Article  Google Scholar 

  80. Penn I. Cancers of the anogenital region in renal transplant recipients. Cancer 1986; 58: 611–6

    Article  PubMed  CAS  Google Scholar 

  81. Euvrard S, Kanitakis J, Chardonnet Y, et al. External anogenital lesions in organ transplant recipients. Arch Dermatol 1997; 133: 175–8

    Article  PubMed  CAS  Google Scholar 

  82. Volgger B, Marth C, Zeimet A, et al. Fulminant course of a microinvasive vulvar carcinoma in an immunosuppressed woman. Gynecol Oncol 1997; 65: 177–9

    Article  PubMed  CAS  Google Scholar 

  83. Longuet M, Cassonet P, Orth G. A novel genital human papillomavirus (HPV), HPV type 74, found in immunosuppressed patients. J Clin Microbiol 1996; 34: 1859–62

    PubMed  CAS  Google Scholar 

  84. Lindelöf B, Sigurgeirsson B, Gäbel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143: 513–9

    PubMed  Google Scholar 

  85. Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996; 61: 274–8

    Article  PubMed  CAS  Google Scholar 

  86. Greene MH. Malignant melanoma in renal transplant recipients. Lancet 1981; II: 1196–9

    Article  Google Scholar 

  87. Lévêque L, Dalac S, Dompmartin A, et al. Melanoma in organ transplant patients [in French]. Ann Dermatol Venereol 2000; 127: 160–5

    PubMed  Google Scholar 

  88. Grob JJ, Bastuji-Garin S, Vaillant L, et al. Excess of nevi related to immunodeficiency: a study in HIV-infected patients and renal transplant recipients. J Invest Dermatol 1996; 197: 694–7

    Article  Google Scholar 

  89. Kanitakis J, Euvrard S, Faure M, et al. Caractéres prolifératifs des naevus chez les enfants greffés d’organe. Ann Dermatol Vénéréol 1999; 126: 687–90

    PubMed  CAS  Google Scholar 

  90. Smith C, McGregor J, Barker J, et al. Excess melanocytic nevi in children with renal allografts. J Am Acad Dermatol 1993; 28: 51–5

    Article  PubMed  CAS  Google Scholar 

  91. Szepietowski J, Wasik F, Szepietowski T, et al. Excess benign melanocytic naevi in renal transplant recipients. Dermatology 1997; 194: 17–9

    Article  PubMed  CAS  Google Scholar 

  92. Penn I, Brunson ME. Cancers after cyclosporine therapy. Transplant Proc 1988; 20: 885–92

    PubMed  CAS  Google Scholar 

  93. Bismuth H, Samuel D, Venancie P, et al. Development of Kaposi’s sarcoma in liver transplant recipients: characteristics, management and outcome. Transplant Proc 1991; 23: 1438–9

    PubMed  CAS  Google Scholar 

  94. Farge D. Kaposi’s sarcoma in organ transplant recipients. Eur J Med 1993; 2: 339–43

    PubMed  CAS  Google Scholar 

  95. Besnard V, Euvrard S, Kanitakis J, et al. Kaposi’s sarcoma after liver transplantation. Dermatology 1996; 193: 100–4

    Article  PubMed  CAS  Google Scholar 

  96. Kadry Z, Bronsther O, Van Thiel DH, et al. Kaposi’ s sarcoma in two primary liver allograft recipients occurring under FK506 immunosuppression. Clin Transplant 1993; 7: 188–94

    PubMed  Google Scholar 

  97. Rezeig MA, Fashir MB, Hainau B, et al. Kaposi’s sarcoma in liver transplant recipients on FK 506: two case reports. Transplantation 1997; 63: 1520–1

    Article  PubMed  CAS  Google Scholar 

  98. Penn I. Sarcomas in organ allograft recipients. Transplantation 1995; 60: 1485–91

    Article  PubMed  CAS  Google Scholar 

  99. Harwood AR, Osoba D, Hofstader SL, et al. Kaposi’s sarcoma in recipients of renal transplants. Am J Med 1979; 67: 759–65

    Article  PubMed  CAS  Google Scholar 

  100. Francès C, Lagrange S. Kaposi’s sarcoma. In: Euvrard S, Kanitakis J, Claudy A, et al., editors. Skin diseases after organ transplantation. Paris: John Libbey Eurotext, 1998: 131–8

  101. Lesnoni La Parola I, Masini C, Nanni G, et al. Kaposi’ s sarcoma in renal-transplant recipients: experience at the catholic university of Rome, 1988–1996. Dermatology 1997; 194: 229–33

    Article  Google Scholar 

  102. Quinibi W, Barri Y, Al-Furayh O, et al. Kaposi’s sarcoma in renal transplant recipients: a report on 26 cases from a single institution. Transplant Proc 1993; 25: 1402–5

    Google Scholar 

  103. Penn I. Kaposi’s sarcoma in transplant recipients. Transplantation 1997; 64: 669–73

    Article  PubMed  CAS  Google Scholar 

  104. Halmos O, Inturri P, Galligioni A, et al. Two cases of Kaposi’s sarcoma in renal and liver transplant recipients treated with interferon. Clin Transplant 1996; 10: 374–8

    PubMed  CAS  Google Scholar 

  105. Colina F, Lopez-Rios F, Lumbreras C, et al. Kaposi’s sarcoma developing in a liver graft. Transplantation 1996; 61: 1779–81

    Article  PubMed  CAS  Google Scholar 

  106. Al-Sulaiman MH, Mousa DH, Rassoul Z, et al. Transplant related Kaposi sarcoma in children. Nephrol Dial Transplant 1994; 9: 443–5

    PubMed  CAS  Google Scholar 

  107. Ozen S, Saatci U, Karaduman A, et al. Kaposi’s sarcoma in a paediatric renal transplant recipient. Nephrol Dial Transplant 1996; 11: 1162–3

    Article  PubMed  CAS  Google Scholar 

  108. Branson ME, Balakrishnan K, Penn I. HLA and Kaposi’s sarcoma in solid organ transplantation. Hum Immunol 1990; 29: 56–63

    Article  Google Scholar 

  109. Burgert S, Strickman N, Carrol C, et al. Cardiac Kaposi’s sarcoma following heart transplantation. Catheter Cardiovasc Interv 2000; 49: 208–12

    Article  PubMed  CAS  Google Scholar 

  110. Kanitakis J, Narvaez D, Claudy A. Expression of the CD34 antigen distinguishes Kaposi’s sarcoma from pseudo-Kaposi’s sarcoma (acroangiodermatitis). Br J Dermatol 1996; 134: 44–6

    Article  PubMed  CAS  Google Scholar 

  111. Weninger W, Partanen TA, Breiteneder-Geleff S, et al. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial origin of Kaposi’s sarcoma tumor cells. Lab Invest 1999; 79: 243–51

    PubMed  CAS  Google Scholar 

  112. Kaaya E, Parravicini C, Sundelin B, et al. Spindle cell ploidy and proliferation in endemic and epidemic African Kaposi’s sarcoma. Eur J Cancer 1992; 28: 1890–4

    Article  Google Scholar 

  113. Delabesse E, Oksenhendler E, Lebbé C, et al. Molecular analysis of clonality in Kaposi’s sarcoma. J Clin Pathol 1997; 50: 664–8

    Article  PubMed  CAS  Google Scholar 

  114. Rabkin CS, Jane S, Lash A, et al. Monoclonal origin of multicentric Kaposi’s sarcoma lesions. N Engl J Med 1997; 336: 988–93

    Article  PubMed  CAS  Google Scholar 

  115. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi’s sarcoma in patients with and those without HIV infection. N Engl J Med 1995; 332: 1181–5

    Article  PubMed  CAS  Google Scholar 

  116. Russo JJ, Bohenzky RA, Chien MC, et al. Nucleotide sequence of the Kaposi sarcoma associated herpesvirus (HHV8). Proc Natl Acad sci USA 1996; 93: 14862–7

    Article  PubMed  CAS  Google Scholar 

  117. Cathomas G. Human herpes virus 8: anew virus discloses its face. Virchows Arch 2000; 436: 195–206

    Article  PubMed  CAS  Google Scholar 

  118. Boshoff C. Kaposi’s sarcoma associated herpesvirus. Cancer Surv 1998; 33: 157–90

    Google Scholar 

  119. Alkan S, Karcher DS, Ortiz A, et al. Human herpesvirus-8/Kaposi’s sarcoma-associated herpesvirus in organ transplant patients with immunosuppression. Br JHaematol 1997; 96: 412–4

    Article  CAS  Google Scholar 

  120. Flore O, Rafii S, Ely S, et al. Transformation of primary human endothelial cells by Kaposi’s sarcoma-associated herpesvirus. Nature 1998; 394: 588–92

    Article  PubMed  CAS  Google Scholar 

  121. Muralidhar S, Pumfrey A, Hassani M, et al. Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus) transforming gene. J Virol 1998; 72: 4980–8

    PubMed  CAS  Google Scholar 

  122. Lebbé C, Agbalika F, de Crémoux P, et al. Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi sarcoma. Arch Dermatol 1997; 133: 25–30

    Article  PubMed  Google Scholar 

  123. Kedda MA, Margolius L, Kew MC, et al. Kaposi’s sarcoma associated herpes virus in Kaposi’s sarcoma occurring in immunosuppressed renal transplant recipients. Clin Transplant 1996; 10: 429–31

    PubMed  CAS  Google Scholar 

  124. Noel JC, De Thier F, Heenen M, et al. HHV-8 is associated with recurrent Kaposi’s sarcoma in a renal transplant recipient. Transplant Int 1997; 10: 81–2

    Article  CAS  Google Scholar 

  125. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi’s sarcoma. Lancet 1995; 346: 799–802

    Article  PubMed  CAS  Google Scholar 

  126. Pozo F, Tenorio A, Dela Mata M, et al. Persistent Human herpesvirus 8 viremia before Kaposi’s sarcoma development in a liver transplant recipient. Transplantation 2000; 70: 395–7

    Article  PubMed  CAS  Google Scholar 

  127. Parravicini C, Olsen SJ, Capra M, et al. Risk of Kaposi’s sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi’s sarcoma patients. Blood 1997; 90: 2826–9

    PubMed  CAS  Google Scholar 

  128. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with or without Kaposi’s sarcoma. Nat Med 1996; 2: 925–8

    Article  PubMed  CAS  Google Scholar 

  129. Francès C, Mouquet C, Marcellin AG, et al. Outcome of kidney transplant recipients with previous human herpeviras-8 infection. Transplantation 2000; 69: 1776–9

    Article  PubMed  Google Scholar 

  130. Cattani P, Nanni G, Capuano M, et al. Pretransplantation human herpes viras 8 seropositivity as a risk factor for Kaposi’s sarcoma in kidney transplant recipients. Transplant Proc 2000; 32: 526–7

    Article  PubMed  CAS  Google Scholar 

  131. Regamey N, Tamm M, Wernli M, et al. Transmission of Human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med 1998; 339: 1358–63

    Article  PubMed  CAS  Google Scholar 

  132. Bottalico D, Santabosti Barbone G, Giancaspro V, et al. Post-transplantation Kaposi’s sarcoma appearing simultaneously in same cadaver donor renal transplant recipients. Nephrol Dial Transplant 1997; 12: 1055–7

    Article  PubMed  CAS  Google Scholar 

  133. Husscin M, Mooij J, Roujouleh H. Regression of posttransplant Kaposi sarcoma after discontinuing cyclosporin and giving mycophenolate mofetil instead. Nephrol Dial Transplant 2000; 15: 1103–4

    Article  Google Scholar 

  134. Shepherd FA, Maher E, Cardella C, et al. Treatment of Kaposi’s sarcoma after solid organ transplantation. J Clin Oncol 1997; 15: 2371–7

    PubMed  CAS  Google Scholar 

  135. Medveczky MM, Horvath E, Lund T, et al. In vitro antiviral drag sensitivity of the Kaposi’s sarcoma-associated herpes virus. AIDS 1997; 11: 1327–32

    Article  PubMed  CAS  Google Scholar 

  136. Al-Sulaiman MH, Mousa DH, Dhar JM, et al. Does regressed posttransplantation Kaposi’s sarcoma recur following reintroduction of immunosuppression? Am J Nephrol 1992; 12: 384–6

    Article  PubMed  CAS  Google Scholar 

  137. Doutrelepont JM, De Pauw L, Gruber SA, et al. Renal transplantation exposes patients with previous Kaposi’s sarcoma to a high risk of recurrence. Transplantation 1996; 62: 463–6

    Article  PubMed  CAS  Google Scholar 

  138. Euvrard S, Kanitakis J, Bosshard S, et al. No recurrence of posttransplantation Kaposi’s sarcoma three years after renal retransplantation. Transplantation 2002; 73: 297–9

    Article  PubMed  Google Scholar 

  139. vanGorp J, Doornewaard H, Verdonck L, et al. Posttransplant T-cell lymphoma: report of three cases and review of the literature. Cancer 1994; 73: 3064–72

    Article  PubMed  Google Scholar 

  140. Ahmed I. Cutaneous B cell post-transplant lymphoproliferative disorder [abstract]. Am J Dermatopathol 2000; 22: 352

    Google Scholar 

  141. Chai C, White W, Shea C, et al. Epstein-Barr virus-associated lymphoproliferative disorders primarily involving the skin. J Cutan Pathol 1999; 26: 242–7

    Article  PubMed  CAS  Google Scholar 

  142. Gonthier D, Hartman G, Holley J. Posttransplant lymphoproliferative disorder presenting as an isolated skin lesion. Am J Kidney Dis 1992; 19: 600–3

    PubMed  CAS  Google Scholar 

  143. Kerr P, Gohn R, Robinson-Bostom L. Cutaneous Epstein-Barr virus-induced posttransplantation lymphoproliferative disorder [abstract]. J Cutan Pathol 2000; 27: 543A

    Google Scholar 

  144. McGregor J, Yu C, Lu Q, et al. Posttransplant cutaneous lymphoma. J Am Acad Dermatol 1993; 29: 549–54

    Article  PubMed  CAS  Google Scholar 

  145. Mozzanica N, Cattaneo A, Fracchiolla N, et al. Posttransplantation cutaneous B cell lymphoma with monoclonal Epstein-Barr viras infection, responding to acyclovir and reduction in immunosuppression. J Heart Lung Transplant 1997; 16: 964–8

    PubMed  CAS  Google Scholar 

  146. Schumann K, Oriba H, Bergfeld W, et al. Cutaneous presentation of posttransplant lymphoproliferative disorder. J Am Acad Dermatol 2000; 42: 923–6

    Article  PubMed  CAS  Google Scholar 

  147. Whittam L, Coleman R, McDonald D. Plasma cell tumour in a renal transplant recipient. Clin Exp Dermatol 1996; 21: 367–9

    Article  PubMed  CAS  Google Scholar 

  148. Tas S, Simonart T, Dargent J, et al. Granulomatose lymphomatoïde à localisation cutanée isolée aprés une transplantation cardio-pulmonaire. Ann Dermatol Venereol 2000; 127: 488–91

    PubMed  CAS  Google Scholar 

  149. Pascual J, Torrelo A, Teruel J, et al. Cutaneous T cell lymphomas after renal transplantation. Transplantation 1992; 53: 1143–5

    Article  PubMed  CAS  Google Scholar 

  150. Ward H, Russo G, McBurney E, et al. Posttransplant primary cutaneous T-cell lymphoma. J Am Acad Dermatol 2001; 44: 675–80

    Article  PubMed  CAS  Google Scholar 

  151. Defossez C, Carmi E, Poulain JE, et al. Lymphome T cutané chez une transplantée rénale [abstract]. Nouv Dermatol 2001; 20 Suppl. 3: 25

    Google Scholar 

  152. Milpied V, Vasseur B, Parquet N, et al. Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients. Ann Oncol 2000; 11 Suppl. 1: 113–6

    Article  Google Scholar 

  153. Heinzerling L, Urbanek M, Funk J, et al. Reduction of tumor burden and stablization of disease by systemic therapy with anti-CD20 antibody (Rituximab) in patients with primary cutaneous B-cell lymphoma. Cancer 2000; 89: 1835–44

    Article  PubMed  CAS  Google Scholar 

  154. Penn I. Posttransplantation de novo tumors in liver allograft recipients. Liver Transpl Surg 1996; 2: 52–9

    Article  PubMed  CAS  Google Scholar 

  155. Somers G, Tesoriero A, Hartland E, et al. Multiple leiomyosarcomas of both donor and recipient origin in a heart-lung transplant patient. Am J Surg Pathol 1998; 22: 1423–8

    Article  PubMed  CAS  Google Scholar 

  156. Lee E, Locker J, Malesnik M, et al. The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 1995; 332: 19–25

    Article  PubMed  CAS  Google Scholar 

  157. Kingma D, Shad A, Tsokos M, et al. Epstein-Barr virus (EBV)-associated smooth muscle tumor arising in a post-transplant patient treated successfully for two PT-EBV associated large cell lymphomas. Am J Surg Pathol 1996; 20: 1511–9

    Article  PubMed  CAS  Google Scholar 

  158. VanGelder T, Vuzevski V, Weimar W. Epstein-Barr virus in smooth muscle tumors [letter]. N Engl J Med 1995; 332: 1719

    Article  PubMed  Google Scholar 

  159. Uribe-Uribe N, Aviles-Salas A, Orozco-Estevez H, et al. Leiomyosarcoma associated with Epstein-Barr virus in an adult with renal transplant [in Spanish]. Rev Invest Clin 1998; 50: 255–8

    PubMed  CAS  Google Scholar 

  160. Dei Tos A, Maestro R, Doglioni C, et al. Ultraviolet-induced p53 mutations in atypical fibroxanthoma. Am J Pathol 1994; 145: 11–7

    Google Scholar 

  161. Paquet P, Pierard G. Invasive atypical fibroxanthoma and eruptive actinic keratoses in a heart transplant recipient. Dermatology 1996; 192: 411–3

    Article  PubMed  CAS  Google Scholar 

  162. Hafner J, Künzi W, Weinreich T. Malignant fibrous histiocytoma and atypical fibroxanthoma in renal transplant recipients. Dermatology 1999; 198: 29–32

    Article  PubMed  CAS  Google Scholar 

  163. Bessis D, Sotto A, Roubert P, et al. Endothelin-secreting angiosarcoma occurring at the site of an arteriovenous fistula for haemodialysis in a renal transplant recipient. Br J Dermatol 1998; 138: 361–2

    Article  PubMed  CAS  Google Scholar 

  164. Wehrli B, Janzen D, Shokeir O, et al. Epithelioid angiosarcoma arising in surgically constructed arteriovenous fistula. Am J Surg Pathol 1998; 22: 1154–9

    Article  PubMed  CAS  Google Scholar 

  165. Medioni L, Costes V, Leray H, et al. Angiosarcome sur fistule artérioveineuse chez un transplanté rénal. Ann Pathol 1996; 16: 200–2

    PubMed  CAS  Google Scholar 

  166. Conlon P, Daly T, Doyle G, et al. Angiosarcoma at the site of a ligated arteriovenousfistula in a renal transplant recipient. Nephrol Dial Transplant 1993; 8: 259–62

    PubMed  CAS  Google Scholar 

  167. Parrott N, Scott P, Freemont A, et al. Angiosarcoma in an arteriovenous fistula following successful renal transplantation-a case report. Transplantation 1993; 55: 676–7

    PubMed  CAS  Google Scholar 

  168. Kibe Y, Kishimoto S, Katoh N, et al. Angiosarcoma of the scalp associated with renal transplantation. Br J Dermatol 1997; 136: 752–6

    Article  PubMed  CAS  Google Scholar 

  169. Alpers C, Biava C, Salvatierra O. Angiosarcoma following renal transplantation. Transplant Proc 1982; 14: 448–51

    PubMed  CAS  Google Scholar 

  170. Studniberg H, Rivers J, Cooke B, et al. The coexistence of lymphangiosarcoma and Kaposi’s sarcoma in a renal transplant recipient. Cancer 1991; 68: 2330–5

    Article  PubMed  CAS  Google Scholar 

  171. Penn I, First M. Merkel’s cell carcinoma in organ recipients. Transplantation 1999; 68: 1717–21

    Article  PubMed  CAS  Google Scholar 

  172. Formica M, Basolo B, Funaro L, et al. Merkel cell carcinoma in renal transplant recipient. Nephron 1994; 68: 399

    Article  PubMed  CAS  Google Scholar 

  173. Gilaberte M, Pujol R, Sierra J, et al. Merkel cell carcinoma developing after bone marrow transplantation. Dermatology 2000; 201: 80–2

    Article  PubMed  CAS  Google Scholar 

  174. Gooptu C, Woolons A, Ross J, et al. Merkel cell carcinoma arising after therapeutic immunosuppression. Br J Dermatol 1997; 137: 637–41

    Article  PubMed  CAS  Google Scholar 

  175. Pham S, Kormos R, Landreneau R, et al. Solid tumors after heart transplantation: lethality of lung cancer. Ann Thorac Surg 1995; 60: 1623–6

    Article  PubMed  CAS  Google Scholar 

  176. Plunket T, Harris A, Ogg C, et al. The treatment of Merkel cell carcinoma and its association with immunosuppression. Br J Dermatol 1998; 139: 345–6

    Article  Google Scholar 

  177. Stempfle H, Mudra H, Angermann C, et al. Rapid growth of cutaneous neuroendocrine (Merkel cell) carcinoma during treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody. J Heart Lung Transplant 1993; 12: 501–3

    PubMed  CAS  Google Scholar 

  178. Urbatsch A, Sams M, Urist M, et al. Merkel cell carcinoma occurring in renal transplant recipients. J Am Acad Dermatol 1999; 41: 289–91

    Article  PubMed  CAS  Google Scholar 

  179. Williams R, Morgan M, Mathieson I, et al. Merkel cell carcinoma in a renal transplant patient: increased incidence? Transplantation 1998; 27: 1396–7

    Article  Google Scholar 

  180. Douds A, Mellotte G, Morgan H. Fatal Merkel-cell tumour (cutaneous neuroendocrine carcinoma) complicating renal transplantation. Nephrol Dial Transpl 1995; 10: 2346–8

    CAS  Google Scholar 

  181. Baron J, Sanchez C, Garcia P. Merkel cell carcinoma in a kidney transplant patient. Rev Clin Esp 2001; 201: 223

    Google Scholar 

  182. Lok C, Luong S, Chaby G, et al. Cutaneous echography at a renal grafted patient presenting multiple histiocytofibromes localised [abstract; in French]. Nouv Dermatol 1998; 17: 627

    Google Scholar 

  183. Boivin S, Catteau B, Provot F, et al. Histiocytofibromes atypiques chez deux patients greffés rénaux [abstract]. Ann Dermatol Venereol 2000; 127 Suppl. 4: 219

    Google Scholar 

  184. Lai K, Lai F, King W, et al. Dermatofibrosarcoma protuberans in a renal transplant patient. Aust N Z Surg 1995; 65: 900–2

    Article  CAS  Google Scholar 

  185. Hadzic N, Pritchard J, Webb D, et al. Recurrence of Langerhans cell histiocytosis in the graft after pediatrie liver transplantation. Transplantation 2000; 70: 815–9

    Article  PubMed  CAS  Google Scholar 

  186. Miller M, Tonsgard J, Soltani K. Late-onset neurofibromatosis in a liver transplant recipient. Int J Dermatol 2000; 39: 376–9

    Article  PubMed  CAS  Google Scholar 

  187. Lemeur Y, Bédane C, Clavère P, et al. A proliferative vascular tumour of the skin in a kidney-transplant recipient (recurrent pyogenic granuloma with satellitosis). Nephrol Dial Transplant 1997; 12: 1271–3

    Article  CAS  Google Scholar 

  188. Otley CC. Organization of a speciality clinic to optimize the care of organ transplant recipients at risk for skin cancer. Dermatol Surg 2000; 26: 709–12

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinique Dermatologique, Hôspital Edouard Herriot, Place d’Arsonval, 69437, Lyon Cedex 03, France

    Sylvie Euvrard, Jean Kanitakis & Alain Claudy

Authors
  1. Sylvie Euvrard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jean Kanitakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alain Claudy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sylvie Euvrard.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Euvrard, S., Kanitakis, J. & Claudy, A. Neoplastic Skin Diseases in Organ Transplant Recipients. Am J Cancer 1, 109–120 (2002). https://doi.org/10.2165/00024669-200201020-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00024669-200201020-00004

Keywords

Search

Navigation